ASAurelio Sessa

Aurelio Sessa

*This is an algorithmically generated author record based on publicly available information.

Aurelio Sessa has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Arterial Thrombosis in an Unusual Site (Ulnar Artery) after COVID-19 Vaccination—A Case Report

    by Aurelio Sessa, Marco Gattamorta, Maurizia Punginelli, Gianluigi Maggioni

    Spontaneous events have been reported after COVID-19 vaccination. In this case, we report a thrombotic event in an unusual site (ulnar artery) after COVID-19 vaccination. The patient (69 year-old-male) had no changes after a laboratory investigation regarding thrombophilic pattern, but nevertheless had atherothrombotic predisposing conditions. Arterial thrombotic events have more frequently been reported after mRNA vaccines than after adenovirus vaccines. This is the first case reported of thrombosis of the ulnar artery occurring in the same side of the body where the vaccination took place. However, it must be noted that COVID-19 vaccines cumulatively offer a net positive effect, despite rare adverse effects.


  • Open Access

    Point-of-Care Testing for Pharyngitis in the Pharmacy

    by Sabiha Essack, John Bell, Douglas Burgoyne, Wirat Tongrod, Martin Duerden, Aurelio Sessa, Attila Altiner, Adrian Shephard

    Pharyngitis (also known as sore throat) is a common, predominately viral, self-limiting condition which can be symptomatically managed without antibiotic treatment. Inappropriate antibiotic use for pharyngitis contributes to the development and spread of antibiotic resistance. However, a small proportion of sore throats caused by group A streptococcal (GAS) infection may benefit from the provision of antibiotics. Establishing the cause of infection is therefore an important step in effective antibiotic stewardship. Point-of-care (POC) tests, where results are available within minutes, can distinguish between viral and GAS pharyngitis and can therefore guide treatment in primary healthcare settings such as community pharmacies, which are often the first point of contact with the healthcare system. In this opinion article, the evidence for the use of POC testing in the community pharmacy has been discussed. Evidence suggests that pharmacy POC testing can promote appropriate antibiotic use and reduce the need for general practitioner consultations. Challenges to implementation include cost, training and ‘who prescribes’, with country and regional differences presenting a particular issue. Despite these challenges, POC testing for pharyngitis has become widely available in pharmacies in some countries and may represent a strategy to contain antibiotic resistance and contribute to antimicrobial stewardship.


  • Open Access

    Incidence of herpes zoster and postherpetic neuralgia in Italian adults aged ≥50 years: A prospective study

    by Andrea Salvetti, Vincenzo Ferrari, Remigio Garofalo, Pietro Gazzaniga, Alessandro Guerroni, Antonio Metrucci, Aurelio Sessa, Maria Loretta Severi, Giulio Nati, Mauro Ruggeri, et al.


  • Open Access

    Multi-disciplinary Consensus Statement Document Vaccinal prevention in adult patients with diabetes mellitus.

    by Giancarlo Icardi, Fausto Francia, Paolo Di Bartolo, Domenico Mannino, Elisabetta Alti, Francesco Purrello, Giorgio Sesti, Aurelio Sessa


    • 10 June 2015
      • Vol. 56  (1) , E9-E11
    Open Access

    Adult immunization schedule. The general practitioner's perspective and new tools for a better practice.

    by A Sessa, A Rossi, I Cricelli

    Vaccine-preventable disease significantly contributes to the morbidity and mortality of adults worldwide. The rates of vaccination against influenza, pneumococcal disease and tetanus in adults and in high-risk group of people are far from the optimal coverage as suggested by Minister of Health. General Practitioners (GPs) can contribute to increase immunization in adults and in elderly people because these age groups attend frequently the surgery of their family doctors for reasons related to their chronic diseases. The GPs, on their side, can proactively involve patients through informatics tools that supply lists of specific patients and electronic alerts in patient records.


  • Open Access

    Prescriber and Patient Responsibilities in Treatment of Acute Respiratory Tract Infections — Essential for Conservation of Antibiotics

    by Alike Van der Velden, Martin G. Duerden, John Bell, John S. Oxford, Attila Altiner, Roman Kozlov, Aurelio Sessa, Antonio C. Pignatari, Sabiha Y. Essack

    Inappropriate antibiotic use in normally self-limiting acute respiratory tract infections (RTIs), such as sore throat and the common cold, is a global problem and an important factor for increasing levels of antibiotic resistance. A new group of international experts—the Global Respiratory Infection Partnership (GRIP)—is committed to addressing this issue, with the interface between primary care practitioners and their patients as their core focus. To combat the overuse of antibiotics in the community, and facilitate a change from prescribing empiric antibiotic treatment towards cautious deferment combined with symptomatic relief, there is a need to introduce and enhance evidence-based dialogue between primary care practitioners and their patients. Communication with patients should focus on the de-medicalisation of self-limiting viral infections, which can be achieved via a coherent globally endorsed framework outlining the rationale for appropriate antibiotic use in acute RTIs in the context of antibiotic stewardship and conservancy. The planned framework is intended to be adaptable at a country level to reflect local behaviours, cultures and healthcare systems, and has the potential to serve as a model for change in other therapeutic areas.


  • Parenteral Antibiotic Therapy in General Practice in Italy: A Direct Observational Study

    by A. Sessa, G. Bettoncelli, A. Rossi, S.E. Giustini

    The aim of this study was to determine the characteristics of parenteral antimicrobial therapy (PAT) in the general practice setting in Italy, the characteristics of patients and the presence of possible external factors (induced prescriptions). 204 General Practitioners (GPs) enrolled during a one-year period the first ten patients to whom they prescribed a PAT, collecting data about clinical characteristics, compliance, outcome and the therapy prescribed or induced. Results indicate that 1,892 patients received a PAT. The use of PAT was preferred for elderly patients. In 55.2% of cases the site of infection was in the lower respiratory tract, followed by urinary tract (14%) and upper respiratory tract (12%). In 98% of cases the route of administration was intramuscular. The first motivation for PAT was in about 50% of cases the severity of the illness, afterward the prescription induced by a specialist in 16% of cases, and in 9% of cases the failure of oral antibiotic therapy.


  • Neuropsychiatric Adverse Drug Reactions in General Practice

    by L. Galatti, S. Ettore Giustini, A. Sessa, G. Polimeni, F. Salvo, E. Spina, A. P. Caputi

    Limited information is available on drug-induced neuropsychiatric disorders in general practice. The present study aimed to examine the spontaneous reports of both neurological and psychiatric adverse drug reactions (ADRs) collected during a two year-period in PharmaSearch database, an Italian database recording reports of ADRs from general practitioners (GPs). Between January 2002 and December 2003, 171 general practitioners sent to PharmaSearch Coordinating Centre a total of 1131 reports corresponding to 1892 ADRs. Of overall reports, 310 (27.4%) involved the central nervous system (CNS) resulting in 440 neuropsychiatric reactions (specifically, 241 neurological and 199 psychiatric). 40 reports were excluded because they were incomplete or contradictory and thus classified as „unlikely“ or „unclassifiable“. Therefore, the present analysis was carried out on 270 reports with 391 neuropsychiatric reactions (213 neurological and 178 psychiatric, respectively). A total of 189 females (70.0%) and 81 males (30.0%) was involved in the 270 reports, and the age of patients with CNS effects was 60.5±15.4 years. Vertigo (16.4%), confusion (10.7%) and headache (10.0%) were the reactions more commonly reported. Drugs indicated for the treatment of nervous system disorders (ATC 1 code=N) accounted only for 38.4% of neuropsychiatric reactions, while most of these reactions were related to drugs indicated for other than nervous system diseases. Non-steroidal anti-inflammatory drugs (NSAIDs), fluoroquinolones, antidepressant drugs, opioids, and proton pump inhibitors (PPIs) were the categories most frequently suspected for neuropsychiatric reactions. Of 391 neuropsychiatric reactions, 78 (19.9%) were unlabeled and 41 (10.5%) were serious. The present study underlines the importance of neuropsychiatric ADRs and reminds GPs to pay attention to this kind of toxicity. Particularly, our findings emphasize the value of neuropsychiatric toxicity from drugs widely used (eg. NSAIDs, antimicrobials and PPIs) and responsible for adverse reactions sometimes underestimated.